Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00067054 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 398 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Minor Re-verified, no change to tracked fields
  3. Minor Eligibility criteria expanded, about 41 words
  4. Minor 10 versions Re-verified since Jul 25, 2026, no change to tracked fieldsv386-v395
  5. Minor Eligibility criteria revised Study description shortened, about 107 wordsv385 Show 1 more changeShow less
    • Study description shortened, about 107 words

    See this version in full on ClinicalTrials.gov ↗

Show 36 earlier versionsHide 36 earlier versions
  1. Minor 8 versions Re-verified since Mar 21, 2026, no change to tracked fieldsv377-v384
  2. Minor Eligibility criteria expanded, about 176 words Study description expanded, about 1 wordv376 Show 1 more changeShow less
    • Study description expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  3. Minor 22 versions Re-verified since Nov 20, 2024, no change to tracked fieldsv354-v375
  4. Minor Study description expanded, about 6 wordsv353 See this version in full on ClinicalTrials.gov ↗
  5. Minor Study Status, Study Descriptionv352
  6. Minor 3 versions Re-verified since Oct 23, 2024, no change to tracked fieldsv349-v351
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study collects specimens from volunteers for use in studies by NIAID's Vaccine Research Center. A number of different types of specimens or samples can be collected, including blood, urine, body fluids or secretions, skin swabs, or skin biopsies. The samples are used for medical research, including the study of HIV, hepatitis, and other diseases; immune system responses, such as responses to vaccinations or infections; and for research on vaccine development. Blood samples may be collected either by ordinary blood drawing (phlebotomy) or by apheresis, a procedure for collecting a larger quantity of blood cells or plasma than would be possible through simple blood drawing. For this procedure, the participant lies on a recliner or couch. Blood is removed through a needle in the vein of one arm and spun in a machine that separates out the desired component (plasma or white blood cells). The remainder of the blood is returned either through the same needle or through a needle in the other arm. The procedure takes about 1 to 3 hours. Volunteers who are 18 years of age and older, including participants in other NIH research protocols, may be eligible. Individuals who have a condition that the research staff considers a reason not to make a sample donation will be excluded from the study. Participants may have only one sample collected or may be asked to undergo repetitive sample collection procedures, depending upon the requirements of the particular research project for which the samples are being collected. Each individual's enrollment is for a 1-year period, which can be extended.
Trial Details
NCT Number NCT00067054
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Conditions Sample Collection
Enrollment 3,000 participants
Start Date
Updated on ClinicalTrials.gov